LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Assets, Deferred Income
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Deferred Tax Assets, Deferred Income of $0 as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2020-02-27
- 2019-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2018-12-31: Deferred Tax Assets, Deferred Income $957.00K.
- 2017-12-31: Deferred Tax Assets, Deferred Income $17.00K.
- 2016-12-31: Deferred Tax Assets, Deferred Income $0.00.
| Period end | Deferred Tax Assets, Deferred Income | Deferred Tax Assets, Deferred Income as first filed |
|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | |
| 2018-12-31 | $957.00K 10-K · filed 2020-02-27 | |
| 2017-12-31 | $17.00K 10-K · filed 2019-02-28 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-01 | |
| 2015-12-31 | $3.00K 10-K · filed 2017-02-28 | |
| 2014-12-31 | $771.00K 10-K · filed 2016-11-14 | $760.00K 10-K · filed 2014-12-01 |
| 2013-12-31 | $760.00K 10-K · filed 2015-02-23 | |
| 2012-12-31 | $1.01M 10-K/A · filed 2014-12-12 |